RENAL CELL CARCINOMA (RCC)
Clinical trials for RENAL CELL CARCINOMA (RCC) explained in plain language.
Never miss a new study
Get alerted when new RENAL CELL CARCINOMA (RCC) trials appear
Sign up with your email to follow new studies for RENAL CELL CARCINOMA (RCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug AB598 enters first human tests
Disease control OngoingThis early-phase trial is testing an experimental drug called AB598, alone or with other cancer drugs, in 40 people with advanced solid tumors like lung, bladder, or breast cancer. The main goal is to check safety and find the right dose. It is not yet known if the drug helps shr…
Matched conditions: RENAL CELL CARCINOMA (RCC)
Phase: PHASE1 • Sponsor: Arcus Biosciences, Inc. • Aim: Disease control
Last updated Jul 02, 2026 03:00 UTC
-
New Dual-Action drug shows promise for kidney cancer patients
Disease control ENROLLING_BY_INVITATIONThis study tests a new medicine called AK112 (Yivoximab) for people with advanced kidney cancer that has spread. The drug works in two ways: it helps the immune system attack cancer cells and blocks blood vessels that feed tumors. About 60 participants will receive the drug every…
Matched conditions: RENAL CELL CARCINOMA (RCC)
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Virus and immunotherapy combo shows promise for Hard-to-Treat cancers
Disease control OngoingThis early-phase trial tests a combination of a modified virus (VSV-IFNβ-NIS) and immunotherapy drugs (pembrolizumab or ipilimumab+nivolumab) in people with advanced solid tumors, including non-small cell lung cancer, neuroendocrine carcinoma, and renal cell carcinoma. The virus …
Matched conditions: RENAL CELL CARCINOMA (RCC)
Phase: PHASE1, PHASE2 • Sponsor: Vyriad, Inc. • Aim: Disease control
Last updated Jun 26, 2026 18:34 UTC
-
Blood test may predict immunotherapy success in lung and kidney cancers
Knowledge-focused OngoingThis study is looking at whether changes in a blood test called tumor fraction can help predict how well immunotherapy works in people with non-small cell lung cancer or kidney cancer. About 100 adults will have blood samples taken before and during their standard treatment. The …
Matched conditions: RENAL CELL CARCINOMA (RCC)
Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC